[1] |
WANG Manli, CHEN Hui, DUAN Zhi, XU Qimei, LI Zhen.
A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis
[J]. China Oncology, 2024, 34(7): 628-638.
|
[2] |
SUN Rongqi, SONG Ning, ZHENG Wentian, ZHANG Xinyue, LI Minmin, GONG Hui, JIANG Yingying.
Effect of long noncoding RNA FLJ30679 on proliferation and migration of oral squamous cell carcinoma cells
[J]. China Oncology, 2024, 34(5): 439-450.
|
[3] |
XIONG Jiayan, LEI Wei, YOU Bo, ZHANG Zhenxin, XIE Haijing, SHAN Ying, XIA Tian, ZHOU Yong.
Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA
[J]. China Oncology, 2024, 34(5): 451-459.
|
[4] |
ZHOU Xueqin, LUAN Yanchao, ZHAO Li, RONG Chaochao, YANG Na.
Expression of CDC20 in lung adenocarcinoma tissues and its effect on the proliferation and invasion of lung adenocarcinoma cells
[J]. China Oncology, 2024, 34(5): 460-472.
|
[5] |
QIAN Bin, CHEN Haiquan.
Important progress in surgical treatment of lung cancer in 2023
[J]. China Oncology, 2024, 34(4): 335-339.
|
[6] |
LIN Yicong, WANG Yue, XUE Qianqian, ZHENG Qiang, JIN Yan, HUANG Ziling, LI Yuan.
Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications
[J]. China Oncology, 2024, 34(4): 368-379.
|
[7] |
JIANG Mengqi, HAN Yuchen, FU Xiaolong.
Research progress on H-E stained whole slide image analysis by artificial intelligence in lung cancer
[J]. China Oncology, 2024, 34(3): 306-315.
|
[8] |
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong.
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer
[J]. China Oncology, 2023, 33(9): 844-856.
|
[9] |
ZHANG Lingling, WANG Xiangyi, WEI Xing, LIN Li, TANG Chuanhao, LIANG Jun.
A study on prevention and treatment of chemotherapy induced nausea and vomiting in non-small cell lung cancer patients with low-frequency electrical stimulator for antiemesis
[J]. China Oncology, 2023, 33(8): 776-781.
|
[10] |
ZHANG Haoting, ZHENG Jing, FU Mengjiao, ZHOU Jianying.
Research progress on thyroid dysfunction induced by immunotherapy for lung cancer
[J]. China Oncology, 2023, 33(7): 701-706.
|
[11] |
WU Jing, ZHOU Juan, SU Chunxia.
Advances in fatty acid metabolism reprogramming of lung cancer
[J]. China Oncology, 2023, 33(5): 517-526.
|
[12] |
CHEN Hong, CHEN Junxia.
Effect of hsa_circ_0001573 on biological behaviors of breast cancer cells and its molecular mechanism
[J]. China Oncology, 2023, 33(4): 342-353.
|
[13] |
SU Chunxia, ZHOU Caicun.
Important clinical research progress in lung cancer in 2022
[J]. China Oncology, 2023, 33(3): 218-227.
|
[14] |
ZOU Chunyuan, XU Xiaofeng, LU Renquan, GUO Lin.
Detection of p53, PGP9.5, SOX2, GAGE7, GBU4-5 and MAGE A1 protein levels in lung cancer tissues and peripheral blood and their clinical value
[J]. China Oncology, 2023, 33(1): 36-44.
|
[15] |
HE Liyuan, WANG Yudong.
Research progress of ALK kinase domain drug resistance mutation and its future countermeasures
[J]. China Oncology, 2022, 32(8): 736-746.
|